Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market to Grow at a CAGR of 7.3% to reach US$ 1,573.67 million from 2022 to 2030

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (Rechargeable and Non-Rechargeable), Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, and Others), End User [Hospitals, Ambulatory Surgery Centers (ASCs), and Others], and Regional Analysis

  • Report Code : TIPRE00030317
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 204
Buy Now

The spinal cord stimulation devices for chronic pain market size is projected to grow from US$ 892.66 million in 2022 to US$ 1,573.67 million by 2030; the market is estimated to register a CAGR of 7.3% from 2022 to 2030.

Analyst’s View Point

The Europe and Middle East spinal cord stimulation devices for chronic pain market analysis explains driving factors such as the rising number of spinal cord injuries (SCIs) and the availability of innovative treatments in the European Union (EU). Further, regenerative and innovative implant-based therapeutic approaches are expected to introduce new trends into the market during 2022–2030. Based on product type, the rechargeable segment accounted for a larger share of the market in 2022. Based on application, the complex regional pain syndrome segment dominated the Europe and Middle East spinal cord stimulation devices for chronic pain market by accounting for a maximum share in 2022. In terms of end user, the hospitals segment is likely to hold a considerable share of the market in Europe and Middle East during the forecast period.

A spinal cord stimulation device is an implanted device that delivers pain relief by transmitting low-level electrical signals directly into the spinal cord. The stimulator is mostly used after nonsurgical pain treatments fail to provide sufficient relief. Additionally, the device can improve the overall quality of life and sleep. As it is typically prescribed along with other pain management treatments, it effectively suppresses the need for pain medicines.

Market Insights

Rising Number of Spinal Cord Injuries Bolsters Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market

According to a report published by the Association for Spinal Injury Research, Rehabilitation and Reintegration (Aspire, UK), ~2,500 people are diagnosed with spinal cord injuries (SCIs) annually in the UK. Currently, ~50,000 people are living with SCIs in the country. An elevated number of cases is attributed to emerging motocross and motorcycling competitions as the most popular sporting activities in the UK, as per the National Institute of Health (NIH) report. With rising motor sporting activities among the youth and senior age group population, there is an increase in the incidence of SCIs among the participants of these events. SCIs have life-changing impacts on the injured patients and their families. The rising incidence of SCIs and the corresponding treatment of patients in hospitals is followed by at least one readmission of the patient every year. This is because SCIs are not treated at once. The causes of rehospitalization include respiratory and urinary tract infections, and fractures occurring during motorcycling sports activities.

The London Spinal Cord Injury Center (LSCIC) is 1 of the 11 organizations in the UK dedicated to treating SCI patients. At the LSCIC, patients undergo a rehabilitation program that takes years and is best delivered through lifelong intervention. With rising SCI and the availability of a well-developed infrastructure in treatment centers providing rehabilitation programs, demand for spinal cord stimulation devices is surging in specialized or rehab centers, which fuels the market growth.

Future Trend

Regenerative and Innovative Implant-Based Therapeutic Approaches

The Comunidad de Madrid claims to be the first in the EU to provide treatments for SCIs using cell and regenerative therapy. Regenerative medicine includes the extraction of mesenchymal stem cells from patients suffering SCIs, treating the extracted cells in a cell production room, and then injecting the regenerated cells at the exact site of SCI or into the cerebrospinal fluid (CSF). Thus, this technique serves as a personalized treatment for SCIs.

The European Commission published a report in September 2022 revealing that scientists are developing new ways to treat SCI using graphene-based implants and virtual reality (VR) illustrations to help improve stroke recovery. They are trying these new approaches to reverse nerve damage, while some researchers are attempting to reshape the architecture of the spinal cord in situ by using engineered materials such as graphene. Graphene is used to create a 3D structure that would skillfully mimic the morphology of the spinal cord. Therefore, the use of such innovative engineered materials and implants successfully exhibits the treatment potential in patients suffering from SCIs. The regenerative and innovative implant-based therapeutic approaches are emerging as new trends in the Europe and the Middle East spinal cord stimulation devices for chronic pain market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market: Strategic Insights

europe-and-middle-east-spinal-cord-stimulation-devices-for-chronic-pain-market
Market Size Value inUS$ 892.66 million in 2022
Market Size Value byUS$ 1,573.67 million by 2030
Growth rateCAGR of 7.3% from 2022 to2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope

Product-Based Insights

Based on product type, the spinal cord stimulation devices for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held the largest market share in 2022, and the same segment is expected to record a significant CAGR during 2022–2030. A spinal cord stimulator, an implantable device, sends low-magnitude electrical signals directly into the spinal cord to offer pain relief. Spinal cord stimulation is mostly employed after nonsurgical pain treatments fail to provide sufficient relief. Several top manufacturers have launched innovative rechargeable spinal cord stimulation devices in the past. In December 2022, Abbott received approval from the US Food and Drug Administration (FDA) for the world's smallest implantable and rechargeable spinal cord stimulation system indicated for chronic pain.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Application-Based Insights

Based on application, the spinal cord stimulation devices for chronic pain market is segmented as failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030. Complex regional pain syndrome (CRPS) involves prolonged pain and inflammation occurring due to an injury or other medical events such as surgery, trauma, stroke, and heart attack. CRPS can occur anywhere in the body, usually affecting the arm, leg, hand, or foot. It is more likely to occur in females and can occur in anyone at any age, with the inflammation approaching a peak after 40 years of age. The majority of CRPS cases are caused due to damaged or improperly functioning small peripheral C-fiber nerve fibers, which carry pain messages to the brain. CRPS often goes undiagnosed with the development of tiny clots, sometimes blocking blood flow to the nerve and injuring it.

End User-Based Insights

In terms of end user, the spinal cord stimulation devices for chronic pain market is categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.

Spinal cord stimulation devices are widely adopted in hospitals to treat patients suffering from SCIs. These devices are implanted via a minor surgery that is often carried out as an outpatient procedure, followed by an overnight stay of patients in the hospital. The hospital infrastructure is well-equipped to successfully use implantable devices such as spinal cord stimulators, which transmit mild electrical pulses directly into the nerve fibers of the patient after implantation, resulting in reduced chronic pain.

Spinal Cord Stimulation Devices for Chronic Pain Market, by Product Type – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis

The Europe spinal cord stimulation devices for chronic pain market is segmented into Sweden, Poland, Belgium, Czech Republic, Greece, Ireland, France, the UK, Switzerland, Italy, Spain, the Netherlands, Slovakia, Germany, and the Rest of Europe. The Middle East spinal cord stimulation devices for chronic pain market is subsegmented into Saudi Arabia, Turkey, Israel, the UAE, Qatar, and Rest of the Middle East. In the EU, Germany contributes a significant share of the spinal cord stimulation devices for chronic pain market. As per the NIH, SCIs are more prevalent in Germany as per the NIH report. Therefore, an increasingly large number of SCI-associated health injuries are sent to SCI centers for rehab programs. These specialized centers are spread across the country, and they provide services such as physical, occupational, and sports therapies as well as physical medicine. Heidelberg University Hospital is an internationally recognized specialized center providing outpatient and in-patient treatments for patients suffering from SCIs. Such innovative treatments provided in specialized centers trigger the demand for spinal cord stimulation devices in Germany.

In the Middle East, Saudi Arabia accounts for a major share of the spinal cord stimulation devices for chronic pain market. According to the 2019 report from the International Journal of Medical Research & Health Sciences, Saudi Arabia has one of the world's highest rates of SCI cases. Such a high burden of SCIs is mainly due to rising road traffic accidents (RTAs). For example, 43.9% of male SCI patients in the country had a cervical injury, followed by 40.4% and 3.5% who suffered from a thoracic injury and a lumbar injury, respectively. Also, physical and psychological distress is claimed to be a prime cause of SCIs among patients in Saudi Arabia. However, early management and rehabilitation can mitigate the long-term complications of SCIs, including hospital stay duration, with prevention as the mainstay of patient care. Various rehabilitation centers have been constructed in Saudi Arabia, as a part of intrinsic modern healthcare delivery services, to overcome challenges posed by a high incidence of SCIs. There are several rehabilitation hospitals/centers in the Kingdom of Saudi Arabia (KSA), mainly in the large cities. These include the Rehabilitation Unit of Prince Sultan Military Medical City of Riyadh, Rehabilitation Unit of King Abdulaziz Medical City, National Guard (Riyadh), Rehabilitation Hospital of King Fahad Medical City (Riyadh), King Saud Medical Complex, Rehabilitation Hospital of Al-Hada Military Hospital (Taif), and Riyadh Care Hospital. With the rising SCI cases among Saudi people, progress in research is expected to result in the rollout of appropriate management programs, effective implementation of primary prevention strategies, and proper allocation of health resources for traumatic conditions.

Leading companies in the Europe and Middle East spinal cord stimulation devices for chronic pain market, which are profiled in this market study, include Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Curonix LLC, Biotronik SE & Co KG, Nevro Corp, Nalu Medical Inc, Cirtec Medical Corp, and Synapse Biomedical Inc.

  • In September 2020, Boston Scientific announced the launch of the WaveWriter Alpha portfolio of spinal cord stimulator (SCS) Systems in the European market. The portfolio comprises four MRI, Bluetooth-enabled implantable pulse generators (IPGs), along with additional personalization options based on patients’ needs. These systems are available in rechargeable/non-rechargeable options which cover multiple areas of pain. 
  • In October 2023, Boston Scientific Corp won US FDA approval for the WaveWriter Alpha SCS systems for the treatment of painful diabetic peripheral neuropathy (DPN), a disorder that can affect the lower limbs of the body.
  • In August 2022, Abbott Laboratories received approval from the US FDA for its Proclaim Plus SCS system to treat chronic pain. The device is enabled with the BurstDR stimulation technology to deliver superior pain relief. It features FlexBurst360 therapy that offers pain coverage across the trunk and limbs, alongside enabling programming that is adjustable as per the patient's evolving therapeutic needs.

Company Profiles

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc  
  • Curonix LLC
  • Biotronik SE & Co KG
  • Nevro Corp
  • Nalu Medical Inc  
  • Cirtec Medical Corp
  • Synapse Biomedical Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, Application, End User, and Regional Analysis

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Europe and Middle East spinal cord stimulation devices for chronic pain?

A spinal cord stimulation device is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. A spinal cord stimulator is mostly used after non-surgical pain treatment options that have failed to provide sufficient relief. Additionally, a spinal cord stimulator can improve the overall quality of life and sleep reduce the need for pain medicines, and it is typically used along with other pain management treatments.

What are the driving factors for the Europe and Middle East spinal cord stimulation devices for chronic pain market across the globe?

Key factors that are driving the growth of this market are rising number of spinal cord injuries and availability of innovative treatments in the European Union (EU).

What is the market CAGR value of Europe and Middle East spinal cord stimulation devices for chronic pain market during forecast period?

The CAGR value of the Europe and Middle East spinal cord stimulation devices for chronic pain market during the forecasted period of 2020-2030 is 7.3%.

Which product type segment leads the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The rechargeable segment held the largest share of the market in the Europe and Middle East spinal cord stimulation devices for chronic pain market and held the largest market share in 2022.

Which end user held the largest share in the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The hospital segment dominated the Europe and Middle East spinal cord stimulation devices for chronic pain market and held the largest market share in 2022.

Who are the key players in the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The Europe and Middle East spinal cord stimulation devices for chronic pain market majorly consists of the players such Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Curonix LLC, Biotronik SE & Co KG, Nevro Corp, Nalu Medical Inc, Cirtec Medical Corp, and Synapse Biomedical Inc.

Which are the top companies that hold the market share in Europe and Middle East spinal cord stimulation devices for chronic pain market?

Boston Scientific Corp and Abbott Laboratories are the top two companies that hold huge market shares in the Europe and Middle East spinal cord stimulation devices for chronic pain market.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

1.2.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Product Type

1.2.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Application

1.2.3 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by End User

1.2.4 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – by Region

2. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Market Landscape

4.1 Overview

4.1.1 Europe and Middle East PEST Analysis

5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market

5.1 Market Drivers

5.1.1 Rising Number of Spinal Cord Injuries

5.1.2 Availability of Innovative Treatments in European Union

5.2 Market Restraints

5.2.1 Product Recalls

5.3 Market Opportunities

5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries

5.4 Future Trends

5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches

5.5 Impact analysis

6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Regional Analysis

6.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis

7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – by Product Type

7.1 Overview

7.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)

7.3 Rechargeable

7.3.1 Overview

7.3.2 Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Rechargeable

7.4.1 Overview

7.4.2 Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

8. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030– by Application

8.1 Overview

8.1.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)

8.2 Failed Back Syndrome

8.2.1 Overview

8.2.2 Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market– Revenue and Forecast to 2030 (US$ Million)

8.3 Complex Regional Pain Syndrome

8.3.1 Overview

8.3.2 Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Degenerative Disk Disease

8.4.1 Overview

8.4.2 Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030– by End User

9.1 Overview

9.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market– Revenue and Forecast to 2030 (US$ Million)

9.4 Ambulatory Surgery Centers (ASCs)

9.4.1 Overview

9.4.2 Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – Regional Analysis

10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030

10.1.1 Overview

10.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.2 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.3 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.4 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries

10.1.2.5 Germany

10.1.2.5.1 Overview

10.1.2.5.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.5.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.5.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.5.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.6 France

10.1.2.6.1 Overview

10.1.2.6.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.6.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.6.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.6.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.7 Italy

10.1.2.7.1 Overview

10.1.2.7.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.7.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.7.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.7.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.8 Spain

10.1.2.8.1 Overview

10.1.2.8.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.8.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.8.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.8.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.9 United Kingdom

10.1.2.9.1 Overview

10.1.2.9.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.9.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.9.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.9.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.10 Switzerland

10.1.2.10.1 Overview

10.1.2.10.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.10.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.10.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.10.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.11 Netherlands

10.1.2.11.1 Overview

10.1.2.11.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.11.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.11.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.11.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.12 Sweden

10.1.2.12.1 Overview

10.1.2.12.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.12.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.12.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.12.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.13 Belgium

10.1.2.13.1 Overview

10.1.2.13.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.13.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.13.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.13.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.14 Poland

10.1.2.14.1 Overview

10.1.2.14.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.14.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.14.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.14.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.15 Slovakia

10.1.2.15.1 Overview

10.1.2.15.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.15.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.15.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.15.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.16 Czech Republic

10.1.2.16.1 Overview

10.1.2.16.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.16.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.16.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.16.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.17 Greece

10.1.2.17.1 Overview

10.1.2.17.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.17.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.17.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.17.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.18 Ireland

10.1.2.18.1 Overview

10.1.2.18.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.18.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.18.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.18.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.2.19 Rest of Europe

10.1.2.19.1 Overview

10.1.2.19.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.19.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.2.19.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.2.19.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – Regional Analysis

11.1 Middle East Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030

11.1.1 Overview

11.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.1 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.2 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.3 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.4 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries

11.1.2.5 Qatar

11.1.2.5.1 Overview

11.1.2.5.2 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.5.3 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.5.4 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.5.5 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.6 Saudi Arabia

11.1.2.6.1 Overview

11.1.2.6.2 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.6.3 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.6.4 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.6.5 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.7 UAE

11.1.2.7.1 Overview

11.1.2.7.2 UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.7.3 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.7.4 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.7.5 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.8 Turkey

11.1.2.8.1 Overview

11.1.2.8.2 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.8.3 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.8.4 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.8.5 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.9 Israel

11.1.2.9.1 Overview

11.1.2.9.2 Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.9.3 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.9.4 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.9.5 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11.1.2.10 Rest of Middle East

11.1.2.10.1 Overview

11.1.2.10.2 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

11.1.2.10.3 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

11.1.2.10.4 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

11.1.2.10.5 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Boston Scientific Corp

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Abbott Laboratories

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Medtronic Plc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Curonix LLC

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Biotronik SE & Co KG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Nevro Corp

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nalu Medical Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Cirtec Medical Corp

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Synapse Biomedical Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

List of Tables

Table 1. Surgical Navigation Systems Market Segmentation

Table 2. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 3. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 4. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 5. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 6. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 7. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 8. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 9. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 10. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 11. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 12. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 13. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 14. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 15. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 16. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 17. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 18. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 19. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 20. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 21. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 22. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 23. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 24. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 25. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 26. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 27. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 28. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 29. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 31. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 32. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 33. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 34. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 35. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 36. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 37. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 38. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 39. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 40. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 41. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 42. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 43. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 44. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 45. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 46. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 47. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 48. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 49. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 50. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 51. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 52. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 53. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 54. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 55. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 56. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 57. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 58. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 59. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 60. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 61. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 62. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 63. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 64. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 65. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 66. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 67. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 68. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type

Table 69. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application

Table 70. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User

Table 71. Organic Developments Done By Companies

Table 72. Inorganic Developments Done By Companies

Table 73. Glossary of Terms

List of Figures

Figure 1. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market, by Region

Figure 2. Key Insights

Figure 3. Europe and Middle East: PEST Analysis

Figure 4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics

Figure 5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints

Figure 6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue Forecast and Analysis – 2021–2030

Figure 7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)

Figure 8. Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)

Figure 11. Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12. Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)

Figure 16. Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17. Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)

Figure 20. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)

Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 37. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)

Figure 38. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 39. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)

Figure 40. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 41. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 42. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 43. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 44. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 45. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 46. Growth Strategies Done by the Companies in the Market (%)

The List of Companies - Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market

  1. Boston Scientific Corp
  2. Abbott Laboratories
  3. Medtronic Plc
  4. Curonix LLC
  5. Biotronik SE & Co KG
  6. Nevro Corp
  7. Nalu Medical Inc  
  8. Cirtec Medical Corp
  9. Synapse Biomedical Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market